何宣林 分词

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

r said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it

rite-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share

当前文章：http://yet7m.fenshuqi.cn/8saqn/lan.html

发布时间：12:28:55